The State Key Laboratory of Brain and Cognitive Sciences, The University of Hong Kong, Pokfulam, Hong Kong.
Laboratory of Neuropsychology, The University of Hong Kong, Rm 656, Jockey Club Tower, Pokfulam Road, Hong Kong, Hong Kong.
Brain Imaging Behav. 2020 Dec;14(6):2311-2322. doi: 10.1007/s11682-019-00183-8.
While strong cross-sectional evidence supported the use of fornix microstructure as a marker for detecting Alzheimer's disease (AD), longitudinal data remains inconclusive on the sequential nature of fornix microstructure abnormalities and AD progression. An unequivocal longitudinal relationship between fornix microstructure and markers of AD progression -memory impairment and hippocampal atrophy, must be established to validate fornix microstructure as a marker of AD progression. We included 115 participants from the Alzheimer's Disease Neuroimaging Initiative across the non-demented AD spectrum- defined as those who had at least one AD risk marker at baseline (e.g., mild cognitive impairment (MCI) due to AD diagnosis, amyloid or ApoE4 positivity) and/or 'cognitively normal individuals who converted to MCI due to AD or AD, with structural and diffusion tensor imaging scans at baseline and two years follow-up. Hippocampal volumes (HV), fractional anisotropy (FA) and mean diffusivity (MD) in the fornix were extracted. Memory was indexed via composite scores of verbal memory tests. Structural equation models tested the bidirectional cross-lagged effects of fornix microstructure, memory, and HV. Impaired memory and smaller HV at baseline significantly predicted worse fornix microstructure (decreased FA and increased MD) two years later. Baseline fornix microstructure was not associated with subsequent changes in memory and HV. Fornix microstructure is compromised likely at a later stage, where significant decline in memory and hippocampal atrophy have occurred. This limits the utility of fornix microstructure in the early detection of AD. Our findings inform the possible pathophysiology and refined the use of AD neural markers.
虽然有强有力的横断面证据支持穹窿微观结构作为检测阿尔茨海默病(AD)的标志物,但关于穹窿微观结构异常与 AD 进展的顺序性质的纵向数据仍不确定。必须明确穹窿微观结构与 AD 进展标志物——记忆障碍和海马萎缩之间的纵向关系,以验证穹窿微观结构作为 AD 进展标志物的有效性。我们纳入了来自阿尔茨海默病神经影像学倡议的 115 名参与者,他们处于非痴呆 AD 谱中——定义为基线时至少有一个 AD 风险标志物的人(例如,由于 AD 诊断、淀粉样蛋白或 ApoE4 阳性而导致的轻度认知障碍 (MCI))和/或“认知正常的个体,由于 AD 或 AD 导致转化为 MCI,在基线和两年随访时有结构和扩散张量成像扫描。提取穹窿内的海马体体积 (HV)、各向异性分数 (FA) 和平均弥散度 (MD)。记忆通过言语记忆测试的综合评分来衡量。结构方程模型测试了穹窿微观结构、记忆和 HV 的双向交叉滞后效应。基线时记忆受损和 HV 较小显著预测两年后穹窿微观结构恶化(FA 降低和 MD 增加)。基线时的穹窿微观结构与随后记忆和 HV 的变化无关。穹窿微观结构可能在更晚的阶段受损,此时记忆和海马体萎缩已经发生明显下降。这限制了穹窿微观结构在 AD 的早期检测中的效用。我们的发现为可能的病理生理学提供了信息,并对 AD 神经标志物的使用进行了细化。